Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate

Ductal adenocarcinoma of the prostate is a rare histological variant that only represents <1% of prostate tumors. This histological variant has several important clinical implications with respect to their evolution, clinical prognosis, and treatment. We report the case of a 64-year-old patient w...

Descripción completa

Detalles Bibliográficos
Autores principales: Linden-Castro, Edgar, Pelayo-Nieto, Marcela, Alias-Melgar, Alejandro, Espinosa-Perezgrovas, Daniel, Ramirez-Galindo, Ivan, Catalan-Quinto, Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033549/
https://www.ncbi.nlm.nih.gov/pubmed/24891969
http://dx.doi.org/10.1155/2014/508305
_version_ 1782317838163247104
author Linden-Castro, Edgar
Pelayo-Nieto, Marcela
Alias-Melgar, Alejandro
Espinosa-Perezgrovas, Daniel
Ramirez-Galindo, Ivan
Catalan-Quinto, Gabriel
author_facet Linden-Castro, Edgar
Pelayo-Nieto, Marcela
Alias-Melgar, Alejandro
Espinosa-Perezgrovas, Daniel
Ramirez-Galindo, Ivan
Catalan-Quinto, Gabriel
author_sort Linden-Castro, Edgar
collection PubMed
description Ductal adenocarcinoma of the prostate is a rare histological variant that only represents <1% of prostate tumors. This histological variant has several important clinical implications with respect to their evolution, clinical prognosis, and treatment. We report the case of a 64-year-old patient with ductal adenocarcinoma of the prostate, which progresses to castration-resistant prostate cancer, that was treated with abiraterone acetate with good clinical response, to our knowledge, the first case of ductal adenocarcinoma of the prostate in treatment with abiraterone acetate.
format Online
Article
Text
id pubmed-4033549
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-40335492014-06-02 Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate Linden-Castro, Edgar Pelayo-Nieto, Marcela Alias-Melgar, Alejandro Espinosa-Perezgrovas, Daniel Ramirez-Galindo, Ivan Catalan-Quinto, Gabriel Case Rep Urol Case Report Ductal adenocarcinoma of the prostate is a rare histological variant that only represents <1% of prostate tumors. This histological variant has several important clinical implications with respect to their evolution, clinical prognosis, and treatment. We report the case of a 64-year-old patient with ductal adenocarcinoma of the prostate, which progresses to castration-resistant prostate cancer, that was treated with abiraterone acetate with good clinical response, to our knowledge, the first case of ductal adenocarcinoma of the prostate in treatment with abiraterone acetate. Hindawi Publishing Corporation 2014 2014-05-07 /pmc/articles/PMC4033549/ /pubmed/24891969 http://dx.doi.org/10.1155/2014/508305 Text en Copyright © 2014 Edgar Linden-Castro et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Linden-Castro, Edgar
Pelayo-Nieto, Marcela
Alias-Melgar, Alejandro
Espinosa-Perezgrovas, Daniel
Ramirez-Galindo, Ivan
Catalan-Quinto, Gabriel
Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate
title Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate
title_full Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate
title_fullStr Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate
title_full_unstemmed Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate
title_short Abiraterone Acetate and Castration Resistant Ductal Adenocarcinoma of the Prostate
title_sort abiraterone acetate and castration resistant ductal adenocarcinoma of the prostate
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033549/
https://www.ncbi.nlm.nih.gov/pubmed/24891969
http://dx.doi.org/10.1155/2014/508305
work_keys_str_mv AT lindencastroedgar abirateroneacetateandcastrationresistantductaladenocarcinomaoftheprostate
AT pelayonietomarcela abirateroneacetateandcastrationresistantductaladenocarcinomaoftheprostate
AT aliasmelgaralejandro abirateroneacetateandcastrationresistantductaladenocarcinomaoftheprostate
AT espinosaperezgrovasdaniel abirateroneacetateandcastrationresistantductaladenocarcinomaoftheprostate
AT ramirezgalindoivan abirateroneacetateandcastrationresistantductaladenocarcinomaoftheprostate
AT catalanquintogabriel abirateroneacetateandcastrationresistantductaladenocarcinomaoftheprostate

Ejemplares similares